Format

Send to

Choose Destination
Pediatr Blood Cancer. 2007 May;48(5):591-2.

Response to subcutaneous therapy with mistletoe in recurrent multisystem Langerhans cell histiocytosis.

Author information

1
Department of Pediatric Oncology/Hematology, Otto-Heubner-Center for Pediatric and Adolescent Medicine, Charité-Universitätsmedizin Berlin, Germany. georg.seifert@charite.de

Abstract

We report a case of histologically proven multisystem (MS) Langerhans cell histiocytosis (LCH) with recurrent disease reactivations after systemic chemotherapy. Through the use of subcutaneous therapy with mistletoe (MT), an inactive disease state was achieved.

PMID:
16261597
DOI:
10.1002/pbc.20649
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center